Tags

Type your tag names separated by a space and hit enter

[Treatment of menstrual cycle associated migraine].
Methods Find Exp Clin Pharmacol. 1982; 4(7):521-3.MF

Abstract

A high percentage of migraine in women is closely related to the menstrual cycle either at the time of ovulation or in the perimenstrual period. It can be assumed that rapid serum fluctuations due to the decline of serum estrogens and or progesterone trigger this type of headache. With respect to a possible endocrine mechanism a hormonal treatment seems to be useful in order to avoid migraine or at least to decrease the complaints. Periovulatory migraine can be easily treated with oral contraceptives (o.c.). In women already taking o.c. with headaches in the perimenstrual period either low dose progestogens (minipill) or 0.5 mg estriol up to three times per day during the whole interval can be tried. In women not taking o.c. a corresponding therapy from day 20 of the cycle is indicated. It is important to choose the dosage to be neutral towards bleeding behavior.

Authors

No affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

7169837

Citation

Rindt, W. "[Treatment of Menstrual Cycle Associated Migraine]." Methods and Findings in Experimental and Clinical Pharmacology, vol. 4, no. 7, 1982, pp. 521-3.
Rindt W. [Treatment of menstrual cycle associated migraine]. Methods Find Exp Clin Pharmacol. 1982;4(7):521-3.
Rindt, W. (1982). [Treatment of menstrual cycle associated migraine]. Methods and Findings in Experimental and Clinical Pharmacology, 4(7), 521-3.
Rindt W. [Treatment of Menstrual Cycle Associated Migraine]. Methods Find Exp Clin Pharmacol. 1982;4(7):521-3. PubMed PMID: 7169837.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment of menstrual cycle associated migraine]. A1 - Rindt,W, PY - 1982/1/1/pubmed PY - 1982/1/1/medline PY - 1982/1/1/entrez SP - 521 EP - 3 JF - Methods and findings in experimental and clinical pharmacology JO - Methods Find Exp Clin Pharmacol VL - 4 IS - 7 N2 - A high percentage of migraine in women is closely related to the menstrual cycle either at the time of ovulation or in the perimenstrual period. It can be assumed that rapid serum fluctuations due to the decline of serum estrogens and or progesterone trigger this type of headache. With respect to a possible endocrine mechanism a hormonal treatment seems to be useful in order to avoid migraine or at least to decrease the complaints. Periovulatory migraine can be easily treated with oral contraceptives (o.c.). In women already taking o.c. with headaches in the perimenstrual period either low dose progestogens (minipill) or 0.5 mg estriol up to three times per day during the whole interval can be tried. In women not taking o.c. a corresponding therapy from day 20 of the cycle is indicated. It is important to choose the dosage to be neutral towards bleeding behavior. SN - 0379-0355 UR - https://www.unboundmedicine.com/medline/citation/7169837/[Treatment_of_menstrual_cycle_associated_migraine]_ L2 - http://www.diseaseinfosearch.org/result/4811 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.